Liu HW - Search Results

1

[Expression of cellular repressor of E1A-stimulated genes in vascular smooth muscle cells of different phenotypes].

Han YL, Liu HW, Kang J, Yan CH, Wang XZ, Zhao LY, Li SH. Han YL, et al. Among authors: liu hw. Zhonghua Yi Xue Za Zhi. 2005 Jan 5;85(1):49-53. Zhonghua Yi Xue Za Zhi. 2005. PMID: 15808078 Chinese.

2

[Expression, antibody production and bioactivity detection of cellular repressor of E1A-stimulated gene].

Han YL, Liu HW, Yan CH, Kang J, Wang XZ, Hu Y. Han YL, et al. Among authors: liu hw. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005 Sep;21(5):570-4. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005. PMID: 16143059 Chinese.

3

Efficacy of stenting for unprotected left main coronary artery disease in 297 patients.

Han YL, Wang SL, Jin QM, Liu HW, Ma YY, Wang ZL, Wang DM, Luan B, Wang G. Han YL, et al. Among authors: liu hw. Chin Med J (Engl). 2006 Apr 5;119(7):544-50. Chin Med J (Engl). 2006. PMID: 16620694

4

[Over-expression of the cellular repressor of E1A-stimulated genes inhibits the apoptosis of human vascular smooth muscle cells in vitro.].

Han YL, Xu HM, Deng J, Hu Y, Kang J, Liu HW, Yan CH. Han YL, et al. Among authors: liu hw. Sheng Li Xue Bao. 2006 Aug 25;58(4):324-30. Sheng Li Xue Bao. 2006. PMID: 16906332 Free article. Chinese.

5

[Efficacy of stenting for selective unprotected left main coronary artery disease: two-year follow-up of 416 patients].

Han YL, Wang SL, Jing QM, Liu HW, Ma YY, Wang ZL, Wang DM, Luan B, Wang G. Han YL, et al. Among authors: liu hw. Zhonghua Yi Xue Za Zhi. 2007 Apr 24;87(16):1109-12. Zhonghua Yi Xue Za Zhi. 2007. PMID: 17672992 Chinese.

6

CREG promotes a mature smooth muscle cell phenotype and reduces neointimal formation in balloon-injured rat carotid artery.

Han Y, Deng J, Guo L, Yan C, Liang M, Kang J, Liu H, Graham AM, Li S. Han Y, et al. Cardiovasc Res. 2008 Jun 1;78(3):597-604. doi: 10.1093/cvr/cvn036. Epub 2008 Feb 11. Cardiovasc Res. 2008. PMID: 18267954

7

Long-term clinical, angiographic, and intravascular ultrasound outcomes of biodegradable polymer-coated sirolimus-eluting stents.

Han Y, Jing Q, Chen X, Wang S, Ma Y, Liu H, Luan B, Wang G, Li Y, Wang Z, Wang D, Xu B, Gao R. Han Y, et al. Catheter Cardiovasc Interv. 2008 Aug 1;72(2):177-83. doi: 10.1002/ccd.21600. Catheter Cardiovasc Interv. 2008. PMID: 18655114

8

Comparison of long-term efficacy of the paclitaxel-eluting stent versus the bare-metal stent for treatment of unprotected left main coronary artery disease.

Han Y, Wang S, Jing Q, Li Y, Liu H, Ma Y, Wang Z, Wang D, Luan B, Wang G, Chen T. Han Y, et al. Am J Cardiol. 2009 Jan 15;103(2):194-8. doi: 10.1016/j.amjcard.2008.08.058. Epub 2008 Oct 30. Am J Cardiol. 2009. PMID: 19121435

9

[Clinical efficacy of intra-aortic balloon pumping in treating patients with acute myocardial infarction with left main coronary artery disease].

Zhao X, Han YL, Wang SL, Wang XZ, Jing QM, Wang B, Wang G, Ma YY, Liu HW. Zhao X, et al. Among authors: liu hw. Zhonghua Yi Xue Za Zhi. 2012 Oct 16;92(38):2685-8. Zhonghua Yi Xue Za Zhi. 2012. PMID: 23290106 Chinese.

10

The efficacy and safety of pharmacoinvasive therapy with prourokinase for acute ST-segment elevation myocardial infarction patients with expected long percutaneous coronary intervention-related delay.

Han YL, Liu JN, Jing QM, Ma YY, Jiang TM, Pu K, Zhao RP, Zhao X, Liu HW, Xu K, Wang G, Wang B, Sun RH, Wang J. Han YL, et al. Among authors: liu jn, liu hw. Cardiovasc Ther. 2013 Oct;31(5):285-90. doi: 10.1111/1755-5922.12020. Cardiovasc Ther. 2013. PMID: 23634911 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,331 results

Search Page

Filters